If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,875.00    9.00 (0.48%)
Bid:
1,878.00
Ask:
1,880.00
Spread: 2.00 (0.106%)
Market Cap: £6.01b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Director/PDMR Shareholding

11 Apr 2022 14:43

RNS Number : 0012I
Hiscox Ltd
11 April 2022
 

 

Hiscox Ltd

 

(the 'Company')

 

Notification of transactions by Persons Discharging Managerial Responsibilities ('PDMR')

 

 

Hamilton, Bermuda (11 April 2021) - On 8 April 2022 awards ("Awards") were made to Executive Directors pursuant to the Company's Performance Share Plan ("Performance Share Plan"), approved by shareholders on 14 May 2020, to acquire ordinary 6.5p shares ("Shares") in the capital of the Company.

 

The Awards granted to the Executive Directors are subject to performance conditions measured over the three financial years from 1 January 2022 to 31 December 2024.

 

The performance measures for the Executive Directors will be as set out in the annual report on remuneration in the Annual Report, with 60% of the awards based on stretching growth in net asset value (NAV) plus dividends targets, measured on a per share basis, and 40% based on relative total shareholder return (TSR) against a group of global insurance peers.

 

The performance conditions for 60% of the Awards are measured against the growth in NAV plus dividends, on a per share basis, and will not vest if the growth in NAV plus dividends per share is less than the risk free rate (RFR) plus 6% per annum. 16% of the award will vest if the growth in NAV plus dividends per share is equal to the RFR plus 6% per annum, rising to 100% vesting if the growth in NAV plus dividends per share is equal to or exceeds the RFR plus 17% per annum.

 

The performance conditions for 40% of the Awards are measured against relative TSR. The relative TSR condition assesses the Company's share price and dividend performance relative to that of the comparator group of companies made up of the Company's closest listed global insurance peers over the three year performance period. 20% of the award will vest if performance is at the median, rising on a straight-line basis to 100% if the performance is in the upper quartile based on ranking.

 

Subject to the satisfaction of the performance conditions, Awards will vest on the third anniversary of their grant. The Awards granted to the Executive Directors are subject to a further two year holding period.

 

Details of the number of Shares over which Awards were granted are set out in the table below.

Executive Directors

Awards

 

HA Hussain

190,355

J Musselle

133,248

 

 

The Awards were granted from Bermuda.

 

The notifications set out below are made in accordance with the UK version of the EU Market Abuse Regulation (2014/596/EU) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

Marc Wetherhill

 

Company Secretary

Hiscox Ltd

+ 1 441 278 8300

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDSBXBDGDB
Date   Source Headline
3rd Mar 20252:56 pmRNSTotal Voting Rights
3rd Mar 202510:30 amRNSSyndicates 33 and 6104 – results and estimates
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:05 amRNSAnnouncement of share repurchase programme
27th Feb 20257:00 amRNSFull Year Results
4th Feb 202512:07 pmRNSTotal Voting Rights
27th Jan 20259:17 amRNSHiscox Ltd announces two new Board appointments
2nd Jan 20255:40 pmRNSTotal Voting Rights
2nd Dec 20242:36 pmRNSTotal Voting Rights
26th Nov 20247:00 amRNSTR-1: Notification of major holdings
11th Nov 20248:00 amRNSSyndicates 33 and 6104 – results and estimates
8th Nov 20247:00 amRNSDirector/PDMR Shareholding
7th Nov 20247:00 amRNSQ3 2024 Trading Statement
1st Nov 20243:32 pmRNSTotal Voting Rights
1st Oct 20242:40 pmRNSTotal Voting Rights
27th Sep 202412:32 pmRNSDirector/PDMR Shareholding
20th Sep 20247:00 amRNSApplication to be Admitted to Official List
17th Sep 20243:35 pmRNSTR-1 Standard form - notification major holdings
12th Sep 20245:35 pmRNSAnnouncement of Scrip Reference Share Price
4th Sep 20247:00 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSAppointment - Jane Guyett to the Hiscox Ltd Board
23rd Aug 20247:00 amRNSHiscox Ltd confirms Interim Chair
22nd Aug 20244:32 pmRNSStatement regarding the death of Jonathan Bloomer
15th Aug 20247:01 amRNSCompletion of share repurchase programme
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20249:47 amRNSSyndicates 33 and 6104 – results and estimates
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSHiscox Ltd interim results
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20244:43 pmRNSTotal Voting Rights
5th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20247:00 amRNSTransaction in Own Shares
19th Jul 202410:36 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.